BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 25277040)

  • 1. Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.
    Lueg G; Gross CC; Lohmann H; Johnen A; Kemmling A; Deppe M; Groger J; Minnerup J; Wiendl H; Meuth SG; Duning T
    Neurobiol Aging; 2015 Jan; 36(1):81-9. PubMed ID: 25277040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
    Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO
    J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial activation and inflammation along the Alzheimer's disease continuum.
    Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
    J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance.
    Bosch B; Arenaza-Urquijo EM; Rami L; Sala-Llonch R; Junqué C; Solé-Padullés C; Peña-Gómez C; Bargalló N; Molinuevo JL; Bartrés-Faz D
    Neurobiol Aging; 2012 Jan; 33(1):61-74. PubMed ID: 20371138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship among diffusion tensor imaging, EEG activity, and cognitive status in mild cognitive impairment and Alzheimer's disease patients.
    Scrascia F; Curcio G; Ursini F; Trotta L; Quintiliani L; Migliore S; Altamura C; Pitocco F; Altavilla R; Melgari JM; Quattrocchi CC; Vernieri F
    J Alzheimers Dis; 2014; 38(4):939-50. PubMed ID: 24121958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition.
    Tokuchi R; Hishikawa N; Kurata T; Sato K; Kono S; Yamashita T; Deguchi K; Abe K
    J Neurol Sci; 2014 Nov; 346(1-2):288-92. PubMed ID: 25248955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there an association between peripheral immune markers and structural/functional neuroimaging findings?
    Frodl T; Amico F
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():295-303. PubMed ID: 23313563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
    Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
    Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease.
    Agosta F; Dalla Libera D; Spinelli EG; Finardi A; Canu E; Bergami A; Bocchio Chiavetto L; Baronio M; Comi G; Martino G; Matteoli M; Magnani G; Verderio C; Furlan R
    Ann Neurol; 2014 Dec; 76(6):813-25. PubMed ID: 25087695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics based identification of differential plasma proteins and changes in white matter integrity as markers in early detection of mild cognitive impaired subjects at high risk of Alzheimer's disease.
    Kumar A; Singh S; Verma A; Mishra VN
    Neurosci Lett; 2018 May; 676():71-77. PubMed ID: 29649488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK Cells are Activated in Amnestic Mild Cognitive Impairment but not in Mild Alzheimer's Disease Patients.
    Le Page A; Bourgade K; Lamoureux J; Frost E; Pawelec G; Larbi A; Witkowski JM; Dupuis G; Fülöp T
    J Alzheimers Dis; 2015; 46(1):93-107. PubMed ID: 25720398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood.
    Lunnon K; Ibrahim Z; Proitsi P; Lourdusamy A; Newhouse S; Sattlecker M; Furney S; Saleem M; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Coppola G; Geschwind D; Simmons A; Lovestone S; Dobson R; Hodges A;
    J Alzheimers Dis; 2012; 30(3):685-710. PubMed ID: 22466004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study.
    Tondelli M; Bedin R; Chiari A; Molinari MA; Bonifacio G; Lelli N; Trenti T; Nichelli P
    Clin Chem Lab Med; 2015 Feb; 53(3):453-60. PubMed ID: 25274948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multielectrode array analysis of cerebrospinal fluid in Alzheimer's disease versus mild cognitive impairment: a potential diagnostic and treatment biomarker.
    Görtz P; Siebler M; Ihl R; Henning U; Luckhaus C; Supprian T; Lange-Asschenfeldt C
    Biochem Biophys Res Commun; 2013 May; 434(2):293-7. PubMed ID: 23541573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific T-cell activation in peripheral blood and cerebrospinal fluid in central disorders of hypersomnolence.
    Lippert J; Young P; Gross C; Meuth SG; Dräger B; Schirmacher A; Heidbreder A
    Sleep; 2019 Feb; 42(2):. PubMed ID: 30445542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractional anisotropy changes in Alzheimer's disease depend on the underlying fiber tract architecture: a multiparametric DTI study using joint independent component analysis.
    Teipel SJ; Grothe MJ; Filippi M; Fellgiebel A; Dyrba M; Frisoni GB; Meindl T; Bokde AL; Hampel H; Klöppel S; Hauenstein K;
    J Alzheimers Dis; 2014; 41(1):69-83. PubMed ID: 24577476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.